Abstract
The initial uses of ultrasound waves in the medical field were limited to the thermal ablation of solid tumors and as a diagnostic tool. Recent advances at the preclinical stage have allowed the use of ultrasound as a powerful tool to improve drug delivery when the agent is administered encapsulated inside a nanoparticle. This spatial and temporal control of drug release, using a non-invasive modality, is a promising approach to decrease the side effects of conventional chemotherapy in cancer treatments, as it reduces the interaction of the anti-neoplastic agent with healthy tissues. In this review, we explain the physics of ultrasound, introduce and discuss several examples on the use of nanoparticles as drug carriers, with a focus on liposomes. Examples of in vitro and in vivo studies are presented and discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 668-688 |
| Number of pages | 21 |
| Journal | Current Molecular Medicine |
| Volume | 17 |
| Issue number | 10 |
| DOIs | |
| State | Published - 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anti-neoplastic agent
- Cancer
- Drug delivery
- Drug release
- Liposomes
- Ultrasound
Fingerprint
Dive into the research topics of 'Liposomes as a promising ultrasound-triggered drug delivery system in cancer treatment'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver